Berenberg Bank Analysts Give Orange (EPA:ORA) a €16.30 Price Target

Share on StockTwits

Berenberg Bank set a €16.30 ($18.95) price objective on Orange (EPA:ORA) in a report released on Friday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

ORA has been the topic of several other research reports. Jefferies Financial Group set a €16.50 ($19.19) target price on shares of Orange and gave the stock a buy rating in a report on Wednesday, December 4th. UBS Group set a €14.40 ($16.74) price target on shares of Orange and gave the company a neutral rating in a report on Thursday. Deutsche Bank set a €17.00 ($19.77) price target on shares of Orange and gave the company a buy rating in a report on Wednesday, December 4th. Goldman Sachs Group set a €18.00 ($20.93) price target on Orange and gave the company a buy rating in a research report on Wednesday, December 4th. Finally, Morgan Stanley set a €15.50 ($18.02) price objective on Orange and gave the stock a neutral rating in a research note on Monday, October 28th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of €16.43 ($19.11).

EPA ORA opened at €13.59 ($15.80) on Friday. Orange has a 1 year low of €13.31 ($15.48) and a 1 year high of €15.80 ($18.37). The company has a fifty day simple moving average of €14.57 and a 200 day simple moving average of €14.00.

About Orange

Orange SA provides a range of fixed telephony and mobile telecommunications, data transmission, and other value-added services to consumers, businesses, and other telecommunications operators in Europe, Africa, and the Middle East. The company offers mobile services, such as voice, SMS, and data; fixed broadband and narrowband services, as well as fixed network business solutions, including voice and data; and convergence packages.

Read More: What is the yield curve?

Analyst Recommendations for Orange (EPA:ORA)

Receive News & Ratings for Orange Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orange and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Arrowhead Pharmaceuticals Inc  Shares Acquired by Nisa Investment Advisors LLC
Arrowhead Pharmaceuticals Inc Shares Acquired by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC Sells 18,900 Shares of Waddell & Reed Financial, Inc.
Nisa Investment Advisors LLC Sells 18,900 Shares of Waddell & Reed Financial, Inc.
Nisa Investment Advisors LLC Increases Holdings in Unitil Co.
Nisa Investment Advisors LLC Increases Holdings in Unitil Co.
Nisa Investment Advisors LLC Grows Position in Generac Holdings Inc.
Nisa Investment Advisors LLC Grows Position in Generac Holdings Inc.
Nisa Investment Advisors LLC Lowers Stock Holdings in Easterly Government Properties Inc
Nisa Investment Advisors LLC Lowers Stock Holdings in Easterly Government Properties Inc
Nisa Investment Advisors LLC Buys 300 Shares of Horizon Therapeutics PLC
Nisa Investment Advisors LLC Buys 300 Shares of Horizon Therapeutics PLC


© 2006-2020 Ticker Report